P2X3 길항제의 제조

합성 방법에 사용되는 P2X3 길항제 및 화학적 중간체의 제조가 본원에 기재된다. Described herein are two processes for the preparation of methyl (5)-2-((2-(2,6-difLuoro-4-(methylcarbamol)phenyl)-7-methylimidaz[l,2-a]pyridine-3-yl)methyl)morpholine-4-carboxylate, a P2X3 antagonist, in a stepwise manner and chemical intermediates used...

Full description

Saved in:
Bibliographic Details
Main Authors GREEN JEREMY, CHAURET NATHALIE, KRONENTHAL DAVID R, VILLENEUVE KARINE
Format Patent
LanguageKorean
Published 18.10.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract 합성 방법에 사용되는 P2X3 길항제 및 화학적 중간체의 제조가 본원에 기재된다. Described herein are two processes for the preparation of methyl (5)-2-((2-(2,6-difLuoro-4-(methylcarbamol)phenyl)-7-methylimidaz[l,2-a]pyridine-3-yl)methyl)morpholine-4-carboxylate, a P2X3 antagonist, in a stepwise manner and chemical intermediates used in the synthetic processes.
AbstractList 합성 방법에 사용되는 P2X3 길항제 및 화학적 중간체의 제조가 본원에 기재된다. Described herein are two processes for the preparation of methyl (5)-2-((2-(2,6-difLuoro-4-(methylcarbamol)phenyl)-7-methylimidaz[l,2-a]pyridine-3-yl)methyl)morpholine-4-carboxylate, a P2X3 antagonist, in a stepwise manner and chemical intermediates used in the synthetic processes.
Author CHAURET NATHALIE
KRONENTHAL DAVID R
GREEN JEREMY
VILLENEUVE KARINE
Author_xml – fullname: GREEN JEREMY
– fullname: CHAURET NATHALIE
– fullname: KRONENTHAL DAVID R
– fullname: VILLENEUVE KARINE
BookMark eNrjYmDJy89L5WSQCDCKMFZ4tWPH26lr3yyY82buDAUQtXADDwNrWmJOcSovlOZmUHZzDXH20E0tyI9PLS5ITE7NSy2J9w4yMjAyMjA0MbAwMHE0Jk4VAGJHKgs
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID KR20220140804A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20220140804A3
IEDL.DBID EVB
IngestDate Fri Jul 19 12:57:29 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20220140804A3
Notes Application Number: KR20227031508
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221018&DB=EPODOC&CC=KR&NR=20220140804A
ParticipantIDs epo_espacenet_KR20220140804A
PublicationCentury 2000
PublicationDate 20221018
PublicationDateYYYYMMDD 2022-10-18
PublicationDate_xml – month: 10
  year: 2022
  text: 20221018
  day: 18
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies BELLUS HEALTH COUGH INC
RelatedCompanies_xml – name: BELLUS HEALTH COUGH INC
Score 3.4078918
Snippet 합성 방법에 사용되는 P2X3 길항제 및 화학적 중간체의 제조가 본원에 기재된다. Described herein are two processes for the preparation of methyl...
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title P2X3 길항제의 제조
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221018&DB=EPODOC&locale=&CC=KR&NR=20220140804A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTFJNU8F9o91U01M0nRNDFMsdJOA9byuQZqZuXGaYZJZKngG39fPzCPUxCvCNIKJIQe2FwZ8Tmg5-HBEYI5KBub3EnB5XYAYxHIBr60s1k_KBArl27uF2LqoQXvHRkagA6jUXJxsXQP8Xfyd1Zydbb2D1PyCwHKgzoSFgYkjMwMrqCENOmnfNcwJtC-lALlScRNkYAsAmpdXIsTAlJ0vzMDpDLt7TZiBwxc65Q1kQnNfsQiDRIBRhLHCqx073k5d-2bBnDdzZyiAqIUbRBmU3VxDnD10gVbEw30U7x2E7B5jMQYWYF8_VYJBASiSZGCYbJQMauebJFskGqRZJAH7FEmpaSlJRmlGkgwy-EySwi8tzcAF4oKKXkMLGQaWkqLSVFlgnVqSJAcOCgDdGH2m
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTFJNU8F9o91U01M0nRNDFMsdJOA9byuQZqZuXGaYZJZKngG39fPzCPUxCvCNIKJIQe2FwZ8Tmg5-HBEYI5KBub3EnB5XYAYxHIBr60s1k_KBArl27uF2LqoQXvHRkagA6jUXJxsXQP8Xfyd1Zydbb2D1PyCwHKgzoSFgYkjMwOrOeh8XlDjKcwJtC-lALlScRNkYAsAmpdXIsTAlJ0vzMDpDLt7TZiBwxc65Q1kQnNfsQiDRIBRhLHCqx073k5d-2bBnDdzZyiAqIUbRBmU3VxDnD10gVbEw30U7x2E7B5jMQYWYF8_VYJBASiSZGCYbJQMauebJFskGqRZJAH7FEmpaSlJRmlGkgwy-EySwi8tz8DpEeLrE-_j6ectzcAFkgIVw4YWMgwsJUWlqbLA-rUkSQ4cLADlcICT
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=P2X3+%EA%B8%B8%ED%95%AD%EC%A0%9C%EC%9D%98+%EC%A0%9C%EC%A1%B0&rft.inventor=GREEN+JEREMY&rft.inventor=CHAURET+NATHALIE&rft.inventor=KRONENTHAL+DAVID+R&rft.inventor=VILLENEUVE+KARINE&rft.date=2022-10-18&rft.externalDBID=A&rft.externalDocID=KR20220140804A